Oncotarget is a leading, peer-reviewed journal that focuses on oncological research. Oncotarget is published weekly. Each issue carries articles that include topics involving ongoing oncological research.
Experts in medicine and heath care believe that a quicker dissemination of information and data derived from ongoing research will aid in advancing these projects. Cures and treatments will be forthcoming more rapidly when important research data is more widely and readily available through reliable outlets like Oncotarget.
Oncotarget is overseen by two experienced individuals from the realm of oncological treatment and research. They are Mikhail Blagosklonny and Andrei V. Gudkov. These two editors are affiliated with the Roswell Cancer Institute.
The remainder of the editorial board is also well credentialed. The editorial board is comprised of over three dozen individuals with a strong background in oncology and related disciplines. Members of the board hail from institutions like Harvard, John Hopkins, and Columbia.
The peer review process at Oncotarget is intense. As mentioned, the editorial board consists of experts, including individuals with strong backgrounds in oncology and related areas.
Dove Press reported that every effort is made to ensure that an article presented in Oncotarget is of the highest standards, presents vital information, and is researched and presented by a reputable, regarded professional.
According to Impact Journals, in addition to publishing articles and papers about oncological research, Oncotarget also carriers articles about research and developments in related areas as well. Because of the connection of this type of work to oncology, Oncotarget has made a commitment to get that type of data before the medical community, and the broader public as well.
Oncotarget is an open source journal. It is available at no cost. The rationale is that a wide distribution of the data presented in journal articles contained in Oncotarget enhances research efforts overall.
Information on submitting an article to Oncotarget is found at the journal’s online website. In addition, information about the peer review process can be accessed there as well.